Integration of <i>PNPLA3</i> and <i>TM6SF2</i> genotypes provides incremental improvement in advanced fibrosis prediction among MASLD patients with type 2 diabetes mellitus. [PDF]
Kim DY +12 more
europepmc +1 more source
Considerations and clinical utility of referral pathways for early detection of liver disease in at-risk populations. [PDF]
Pustjens J +4 more
europepmc +1 more source
Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH). [PDF]
Van Kleef LA +4 more
europepmc +1 more source
Prevalence of Hepatic Fibrosis and Performance of Non-invasive Liver Fibrosis Scores in an Eastern Indian Diabetic Population with NAFLD. [PDF]
Sanyal D +8 more
europepmc +1 more source
Non-invasive tests for MetALD and alcohol-related liver disease. [PDF]
Johansen S, Thiele M, Krag A.
europepmc +1 more source
Comparative analysis of non-invasive fibrosis markers: Insights from chronic HBV, HBV+HDV, and HCV infections. [PDF]
Khikmatullaeva AS +9 more
europepmc +1 more source
Harnessing machine learning for the development, validation, and prognostic evaluation of MASHRisk score: insights from a multicohort study. [PDF]
Ye B +8 more
europepmc +1 more source
A New Sign in UV Dermoscopy for Diagnosing Pthiriasis: The Glowing Crab Louse Sign. [PDF]
Zaim A, Douhi Z, Soughi M, Mernissi FZ.
europepmc +1 more source

